Overexpression of miR-26b decreases the cisplatin-resistance in laryngeal cancer by targeting ATF2

Cisplatin is a common used chemotherapeutic drug for the treatment of laryngeal cancer. However, drug-resistance is a major obstacle in platinum-based chemotherapy for laryngeal cancer. Recent studies have demonstrated that dysregulation of microRNAs (miRNAs) is responsible for chemoresistance in mu...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncotarget
Главные авторы: Tian, Linli, Zhang, Jiarui, Ren, Xiuxia, Liu, Xinyu, Gao, Wei, Zhang, Chen, Sun, Yanan, Liu, Ming
Формат: Artigo
Язык:Inglês
Опубликовано: Impact Journals LLC 2017
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5668017/
https://ncbi.nlm.nih.gov/pubmed/29108284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20784
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы